ClinicalTrials.Veeva

Menu
I

IMAX Clinical Trials, LLC. | La Palma, CA

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Obeldesivir
Lunsekimig
Rocatinlimab
SAR440340
PF-07275315

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

5 of 7 total trials

A Phase 2, Dose Ranging Study Assessing Rocatinlimab in Moderate-to-severe Asthma

The primary objective of this study is to describe the efficacy of rocatinlimab in reducing asthma exacerbations.

Active, not recruiting
Asthma
Drug: Placebo
Drug: Rocatinlimab

The purpose of this trial is to assess the safety and relative efficacy of CVXGA (CVXGA50), a KP.2 containing vaccine, compared to COMIRNATY® (COVID-...

Active, not recruiting
COVID-19
Biological: CVXGA (CVXGA50)
Biological: COMIRNATY®

This is a parallel, double blind, Phase 3, 2-arm study that is designed to provide additional safety information, assess the durability of treatment...

Active, not recruiting
Chronic Obstructive Pulmonary Disease
Drug: Placebo
Drug: Itepekimab (SAR440340)

The purpose of this clinical trial is to learn about the effects and safety of the study medicine PF-07275315 for the potential treatment of COPD. CO...

Enrolling
Moderate to Severe Chronic Obstructive Pulmonary Disease
Drug: Placebo
Drug: PF-07275315-dose 2

This is a parallel, Phase 2b/Phase 3, 3-arm study to investigate the efficacy, safety, and tolerability of subcutaneous (SC) treatment with lunsekimi...

Enrolling
Chronic Obstructive Pulmonary Disease
Drug: Lunsekimig
Drug: Placebo

Trial sponsors

Sanofi logo
Amgen logo
C
Gilead Sciences logo
Pfizer logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems